Cargando…

Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study

OBJECTIVE: To assess the feasibility of contrast-enhanced spectral mammography (CESM) of the breast for assessing the size of residual tumors after neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS: In breast cancer patients who underwent NAC between 2011 and 2013, we evaluated residual tumor me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barra, Filipe Ramos, de Souza, Fernanda Freire, Camelo, Rosimara Eva Ferreira Almeida, Ribeiro, Andrea Campos de Oliveira, Farage, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Colégio Brasileiro de Radiologia e Diagnóstico por Imagem 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586512/ https://www.ncbi.nlm.nih.gov/pubmed/28894329 http://dx.doi.org/10.1590/0100-3984.2016-0029

Ejemplares similares

Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
por: Barra, Filipe Ramos, et al.
Publicado: (2018)

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI
por: Savaridas, Sarah L, et al.
Publicado: (2023)

Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
por: Iotti, Valentina, et al.
Publicado: (2017)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Zhang, Kun, et al.
Publicado: (2023)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management
por: Houben, Ivo PL, et al.
Publicado: (2019)

Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis
por: Suter, Matteo Basilio, et al.
Publicado: (2020)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography with a compact synchrotron source
por: Heck, Lisa, et al.
Publicado: (2019)

Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor
por: An, Yeong Yi, et al.
Publicado: (2017)

Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapy
por: Xing, Dong, et al.
Publicado: (2021)

Quantitative Analysis of Enhancement Intensity and Patterns on Contrast-enhanced Spectral Mammography
por: Liu, Ying, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size
por: Nicosia, Luca, et al.
Publicado: (2021)

Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
por: Iotti, Valentina, et al.
Publicado: (2021)

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts
por: Rudnicki, Wojciech, et al.
Publicado: (2021)

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

Retrospective Comparison of Contrast-Enhanced Spectral Mammography with Digital Mammography in Assessing Tumor Size in 668 Cases of Breast Cancer
por: Lorek, Andrzej, et al.
Publicado: (2020)

The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI
por: Lobbes, Marc B.I., et al.
Publicado: (2015)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
por: La Forgia, Daniele, et al.
Publicado: (2020)

Contrast-enhanced spectral mammography: are kinetic patterns useful for differential diagnoses of enhanced lesions?
por: Rong, Xiaocui, et al.
Publicado: (2023)

Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology—preliminary results
por: Rudnicki, Wojciech, et al.
Publicado: (2019)

Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions
por: Xing, Dong, et al.
Publicado: (2019)

Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images
por: Fanizzi, Annarita, et al.
Publicado: (2019)

Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review
por: Zanardo, Moreno, et al.
Publicado: (2019)

Contrast‐enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients
por: Qin, Yun, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts
por: Lu, Zhongfei, et al.
Publicado: (2020)

A meta‐analysis of contrast‐enhanced spectral mammography versus MRI in the diagnosis of breast cancer
por: Xiang, Wanqing, et al.
Publicado: (2020)

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
por: Massafra, Raffaella, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy
por: James, Jonathan
Publicado: (2022)

Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients
por: Feng, Lei, et al.
Publicado: (2022)

A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography
por: Nicosia, Luca, et al.
Publicado: (2022)

Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
por: Lalji, U. C., et al.
Publicado: (2015)

Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China
por: Wang, Qingguo, et al.
Publicado: (2016)

Radiomics Analysis on Contrast-Enhanced Spectral Mammography Images for Breast Cancer Diagnosis: A Pilot Study
por: Losurdo, Liliana, et al.
Publicado: (2019)

Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours
por: Dominique, Caroline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1q0j4auke71jvag7ribg79ff4v